000 01231 a2200349 4500
005 20250517202336.0
264 0 _c20190122
008 201901s 0 0 eng d
022 _a1945-2403
024 7 _a10.1093/jat/bky012
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aAmeline, Alice
245 0 0 _aCharacterization of Flunitrazolam, a New Designer Benzodiazepine, in Oral Fluid After a Controlled Single Administration.
_h[electronic resource]
260 _bJournal of analytical toxicology
_c07 2018
300 _ae58-e60 p.
_bdigital
500 _aPublication Type: Letter
650 0 4 _aAdministration, Oral
650 0 4 _aBenzodiazepines
_xadministration & dosage
650 0 4 _aChromatography, Liquid
650 0 4 _aDesigner Drugs
_xadministration & dosage
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aSaliva
_xmetabolism
650 0 4 _aTandem Mass Spectrometry
700 1 _aRicheval, Camille
700 1 _aGaulier, Jean-Michel
700 1 _aRaul, Jean-Sébastien
700 1 _aKintz, Pascal
773 0 _tJournal of analytical toxicology
_gvol. 42
_gno. 6
_gp. e58-e60
856 4 0 _uhttps://doi.org/10.1093/jat/bky012
_zAvailable from publisher's website
999 _c28104377
_d28104377